395
Participants
Start Date
April 26, 2019
Primary Completion Date
September 29, 2024
Study Completion Date
December 17, 2024
Lactose Placebo
One capsule by mouth twice per day
Ketotifen Fumarate 2mg
2 mg tablets (over-encapsulated into one capsule) by mouth twice per day
Ketotifen Fumarate 5mg
5 mg tablets (over-encapsulated into one capsule) by mouth twice per day
University of Maryland Medical Centre, Baltimore
Carolinas Medical Center, Charlotte
University of Vermont Medical Center, Burlington
Peter Lougheed Centre, Calgary
Foothills Medical Centre, Calgary
South Health Campus, Calgary
Sturgeon Community Hospital, St. Albert
Royal Columbia Hospital, New Westminster
St. Paul's Hospital, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
St. Joseph's Health Care London, London
The Ottawa General Hospital, Ottawa
The Ottawa Civic Hospital, Ottawa
Sunnybrook Health Sciences Centre, Toronto
St. Michael's Hospital, Toronto
United States Department of Defense
FED
University of Calgary
OTHER